vimarsana.com

Page 17 - காமன்வெல்த் ஆஃப் கெந்‌டகீ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bay Area Reporter :: LGBTQ Agenda: SCOTUS litigant discusses ministering to queer Catholics

Bay Area Reporter :: LGBTQ Agenda: SCOTUS litigant discusses ministering to queer Catholics
ebar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ebar.com Daily Mail and Mail on Sunday newspapers.

Bay Area Reporter :: LGBTQ Agenda: SCOTUS litigant discusses ministering to queer Catholics

Bay Area Reporter :: LGBTQ Agenda: SCOTUS litigant discusses ministering to queer Catholics
ebar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ebar.com Daily Mail and Mail on Sunday newspapers.

The Best 3 Weeks of Your Life : UK, GSA Alumna Enjoys Opportunity to Give Back to Kentucky s Young Artists

The Best 3 Weeks of Your Life : UK, GSA Alumna Enjoys Opportunity to Give Back to Kentucky s Young Artists
uky.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uky.edu Daily Mail and Mail on Sunday newspapers.

Kentucky plant begins nerve-agent rocket destruction campaign

13 July 2021 RESTON, Va. Bechtel-led team takes on next inventory of chemical weapons A Bechtel-led plant in Kentucky has successfully begun destroying its next batch of chemical weapons, just two months after completing a previous campaign. The first M55 rockets containing VX nerve agent were destroyed July 9 at the Blue Grass Chemical Agent-Destruction Pilot Plant (BGCAPP), near Richmond, Kentucky. Nearly 18,000 rockets containing VX will be destroyed in the campaign. “Our team has successfully completed two projectile campaigns involving nerve agent,” said Ron Hink, Bechtel Parsons Blue Grass project manager. “As with previous campaigns, safety will remain the top priority as we begin rocket destruction.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.